Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease
Amritha Chakkittukandiyil, Deepak Vasudevan Sajini, Arjunan Karuppaiah, et al.
Neurochemistry International (2022) Vol. 156, pp. 105325-105325
Closed Access | Times Cited: 43

Showing 26-50 of 43 citing articles:

Gene network analysis combined with preclinical studies to identify and elucidate the mechanism of action of novel irreversible Keap1 inhibitor for Parkinson’s disease
Monisha Arumugam, Ranjith Sanjeeve Pachamuthu, Emdormi Rymbai, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1
Activation of the Nrf2/Keap1 signaling pathway mediates the neuroprotective effect of Perillyl alcohol against cerebral hypoxic-ischemic damage in neonatal rats
Yu Fang, Yihui Zheng, Qiqi Gao, et al.
Redox Report (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Targeting the Sirtuin–1/PPAR–Gamma Axis, RAGE/HMGB1/NF-κB Signaling, and the Mitochondrial Functions by Canagliflozin Augments the Protective Effects of Levodopa/Carbidopa in Rotenone-Induced Parkinson’s Disease
M.H.R. El-Kady, Ahmed M. Kabel, Lamees M. Dawood, et al.
Medicina (2024) Vol. 60, Iss. 10, pp. 1682-1682
Open Access | Times Cited: 1
Icariside II Suppresses Ferroptosis to Protect Against MPP+-Induced Parkinson's Disease through Keap1/Nrf2/GPX4 Signaling
Wenbo Fan, Jianwu Zhou
The Chinese Journal of Physiology (2023) Vol. 66, Iss. 6, pp. 437-445
Open Access | Times Cited: 4
Lactic Acid Bacteria-Derived Exopolysaccharides Mitigate the Oxidative Response via the NRF2-KEAP1 Pathway in PC12 Cells
Seda Şirin
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 8071-8090
Open Access | Times Cited: 3
Melatonin Protects Against Titanium Oxide-Induced Neurotoxicity: Neurochemical, Neurobehavioral, and Histopathological Evidences
Sarvenaz Sobhani, Aliasghar Tehrani, Golnar Sobhani, et al.
Biological Trace Element Research (2022) Vol. 201, Iss. 8, pp. 3861-3881
Closed Access | Times Cited: 5
The Impact of Catalpol on Proliferation, Apoptosis, Migration, and Oxidative Stress of Lung Cancer Cells Based on Nrf2/ARE Signaling
Huanyuan Wang, Jingtao Wu, Haiyin Fan, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 4
The role of Nrf2 signaling pathways in nerve damage repair
Arash Abdolmaleki, Aida Karimian, Seyedeh Mahdieh Khoshnazar, et al.
Toxicology Research (2024) Vol. 13, Iss. 3
Closed Access
GLP‐1 receptor agonist liraglutide alleviates kidney injury by regulating nuclear translocation of NRF2 in diabetic nephropathy
Tingting Lin, Yuze Zhang, Qifeng Wei, et al.
Clinical and Experimental Pharmacology and Physiology (2024) Vol. 51, Iss. 12
Closed Access
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12613-12613
Open Access
Synthesis and evaluation of novel ethyl ferulate derivatives as potent Keap1 inhibitors to activate the Nrf2/ARE pathway in Parkinson's disease
Amritha Chakkittukandiyil, Deepak Vasudevan Sajini, Emdormi Rymbai, et al.
Toxicology and Applied Pharmacology (2024), pp. 117172-117172
Closed Access
Antioxidant Potential of Rhodiola Heterodonta Extract: Activation of Nrf2 Pathway via Integrative in Vivo and in Silico Studies
Izzatullo Ziyoyiddin o`g`li Abdullaev, Anvarbek Ilhom O`g`li Bogbekov, Azizbek Akbar ogli, et al.
(2024)
Closed Access
Theoretical studies on the antioxidant activity of potential marine xanthones
Phan Thi Thuy, Nguyen Xuan Ha
Free Radical Research (2024), pp. 1-15
Closed Access
Emerging role of Nrf2 in Parkinson’s disease therapy: a critical reassessment
Veerta Sharma, Prateek Sharma, Thakur Gurjeet Singh
Metabolic Brain Disease (2024) Vol. 40, Iss. 1
Closed Access
Defense Against Oxidative Stress: Nrf2-ARE Pathway
Chang‐Hwei Chen
(2024), pp. 151-160
Closed Access
The Promotion of Antioxidant and Anti-Inflammatory Activity by Nrf2 Amplifier is A Potential Technique in Diabetic Wound Healing — A Review
Tharani Mohanasundaram, Vadivelan Ramachandran, Bhargav Bhongiri, et al.
Pharmaceutical Sciences (2022) Vol. 29, Iss. 3, pp. 255-262
Open Access | Times Cited: 3
Engineering piperlongumine-inspired analogs as Nrf2-dependent neuroprotectors against oxidative damage by an electrophilicity-based strategy
Qi Wang, Lin Dong, Xuefeng Liu, et al.
Free Radical Biology and Medicine (2022) Vol. 194, pp. 298-307
Closed Access | Times Cited: 1
Synergistic protection by Araloside A with L-ascorbic acid on oxidative stress via Nrf2/CAT activation in HEK293 cells
Yaqin Tian, Z. Ou, Fumin Li, et al.
Journal of Functional Foods (2023) Vol. 110, pp. 105841-105841
Open Access
Novel Cyclic Cyanoenone Derivatives as KEAP1Modulators for Treating Neurodegenerative Diseases
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 5, pp. 777-778
Open Access
Previous Page - Page 2

Scroll to top